PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $478,472,000 | +8.2% | 151,896 | 0.0% | 0.00% | – |
| Q2 2020 | $442,017,000 | -5.8% | 151,896 | -8.7% | 0.00% | – |
| Q1 2020 | $469,049,000 | -9.2% | 166,329 | +4.4% | 0.00% | – |
| Q4 2019 | $516,776,000 | +82.2% | 159,253 | +21.3% | 0.00% | – |
| Q3 2019 | $283,680,000 | -25.6% | 131,334 | +8.2% | 0.00% | – |
| Q2 2019 | $381,136,000 | -15.6% | 121,381 | 0.0% | 0.00% | – |
| Q1 2019 | $451,537,000 | +59.2% | 121,381 | +24.1% | 0.00% | – |
| Q4 2018 | $283,678,000 | +9.1% | 97,820 | -1.0% | 0.00% | – |
| Q3 2018 | $259,967,000 | +7.7% | 98,847 | -4.1% | 0.00% | – |
| Q2 2018 | $241,285,000 | -20.4% | 103,113 | 0.0% | 0.00% | – |
| Q1 2018 | $303,152,000 | -22.7% | 103,113 | -28.0% | 0.00% | – |
| Q4 2017 | $392,272,000 | -16.1% | 143,165 | +3.8% | 0.00% | – |
| Q3 2017 | $467,385,000 | +37.2% | 137,872 | 0.0% | 0.00% | – |
| Q2 2017 | $340,543,000 | +8.8% | 137,872 | 0.0% | 0.00% | – |
| Q1 2017 | $312,969,000 | +177723.3% | 137,872 | +66.1% | 0.00% | – |
| Q4 2016 | $176,000 | -54.5% | 82,989 | -28.1% | 0.00% | – |
| Q3 2016 | $387,000 | +6.9% | 115,489 | 0.0% | 0.00% | – |
| Q2 2016 | $362,000 | -6.0% | 115,489 | 0.0% | 0.00% | – |
| Q1 2016 | $385,000 | -47.3% | 115,489 | -44.0% | 0.00% | -100.0% |
| Q4 2015 | $730,000 | -28.1% | 206,223 | +2.1% | 0.00% | 0.0% |
| Q3 2015 | $1,016,000 | -15.0% | 202,023 | +8.7% | 0.00% | 0.0% |
| Q2 2015 | $1,195,000 | +5.6% | 185,841 | +15.6% | 0.00% | 0.0% |
| Q1 2015 | $1,132,000 | +26.8% | 160,765 | +38.9% | 0.00% | 0.0% |
| Q4 2014 | $893,000 | +8.2% | 115,765 | +4.9% | 0.00% | 0.0% |
| Q3 2014 | $825,000 | -10.1% | 110,365 | +16.3% | 0.00% | 0.0% |
| Q2 2014 | $918,000 | +22.6% | 94,865 | +5.2% | 0.00% | 0.0% |
| Q1 2014 | $749,000 | +120.9% | 90,165 | +124.3% | 0.00% | – |
| Q4 2013 | $339,000 | +2.1% | 40,196 | -3.4% | 0.00% | – |
| Q3 2013 | $332,000 | +3.4% | 41,596 | 0.0% | 0.00% | – |
| Q2 2013 | $321,000 | – | 41,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |